Clinical Trials Browser

Phase 1/2 × INDUSTRY × sulindac sulfone × Clear all

NCT00072618 2011-10-20

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Phase 1/2 Completed

NSCLC